1Fenwei W,Stotrffer GA,Waxman S,et al. Late torontory stent thrombosis: Earl), vs. late stent thrombosis In the slent era. Commentary[J]. Catheterization and Cardiovascular Interventions.2002, 55(2): 142-9.
2Trabatloni D,Fabbioechi F,Montorsi P,et al. Stent thrombosis after sirolimusand paclitaxel eluting stent implantalion in daily clinical praelice: analysis of asingle center registry[J]. Catheler Cardiovasc lnterv,2007,70(3):415-21.
3Farb A, Burke AP, Kolodgie FD ,et al. Pathological mechanisms of fatallate coronary stent thrombosis in humans[J]. Circulation,2003,108(14):1701-1706.
4Eikelboom JW,Hankey GJ. Failure of aspirin to prevent atherothrombosis:potential mechanisms and implications for clinical practice[J]. Am J Car-diovasc Drugs,2004,4(1) :57-67.
5Nguyen TA,Diodati JG,Pharand C. Resistance to clopidogrel : A review ofthe evidence[J]. J Am Coll Cardiol, 2005,45 (8) : 1157-1164.
6Muller I,Besta F,Schulz C,et al. Prevalence of clopidogrel non-respondersamong patients with stable angina pectoris scheduled for elective coro-nary stent placement[J]. Thromb Haemost, 2003,89 (5 ) :783-787.
7Cheneau E,Leborgne L,Mintz GS. Predictors of subacute stent throm bo-sis: results of a system atic in travascular ultrasound study[J]. Circulation,2003,108(1):43-47.
8Bavry AA ,Bhatt DL. Appropriate use of drug-eluting stents : balancingthe reduction in restenosis with the concern of late thrombosis[J]. Lancet,2008,371(9630):2134-2143.
